Sorbonne Université, Department of Digestive Surgery, AP-HP, Hôpital Saint Antoine, Paris, France.
Department of Surgical Oncology, Institut Paoli-Calmettes, Marseille, France.
Surgery. 2020 Nov;168(5):786-792. doi: 10.1016/j.surg.2020.06.021. Epub 2020 Aug 5.
Bladder invasion by colon cancer is rare; however, its management is still controversial. Our objective was to report outcomes and identify risk factors for local recurrence in colon cancer with clinically suspected bladder invasion.
We conducted a retrospective study in 23 centers in France. All patients who underwent colon surgery with bladder resection (2010-2017) were included. Metastatic and recurrent colon cancers were excluded.
One hundred and seventeen patients (men = 73) were included. Partial cystectomy occurred in 108 patients (92.3%), with a total cystectomy occurring in 9 patients (7.7%). Neoadjuvant treatment was given to 31 patients (26.5%). Major morbidity was 20.5%. R0 resection rates were 87.2%. Histologically confirmed bladder invasion was present in 47%. Thirty-four patients were pN+, while 60 patients (51.3%) received adjuvant chemotherapy. Mean follow-up was 33.8 months. Three-year overall survival and disease-free survival were 82.9% and 59.5%. Rates of local recurrence and distant recurrence were 14.5% and 18.8%, respectively; the local recurrences (11/17; 65%) were in the bladder, while 4 of these patients had a bladder recurrence despite not having histologically confirmed bladder invasion at the index surgery. The rate of bladder recurrence after histologic bladder invasion was 13% (7/55), while the rate of bladder recurrence without primary bladder invasion was 7% (4/62) (P = .343). Neoadjuvant therapy, type of cystectomy, and adjuvant therapy did not influence local recurrence (P > .445 each). R1 bladder resections, when compared with a R0 bladder resections, were associated with an increased rate of local recurrence (63% vs 10%; P < .0001).
Clinically suspected bladder invasion increases local recurrence even in the absence of histologically confirmed bladder invasion. Only complete resections with R0 margins decrease local recurrence. Careful, detailed postoperative surveillance is required, even without pathologic bladder invasion.
结肠癌侵犯膀胱较为罕见,但治疗方法仍存在争议。本研究旨在报告临床疑似膀胱癌侵犯的结肠癌患者的结局,并确定局部复发的危险因素。
本研究回顾性纳入了 2010 年至 2017 年期间在法国 23 个中心接受结肠手术和膀胱切除术的患者。排除转移性和复发性结肠癌患者。
共纳入 117 例患者(男性 73 例)。108 例患者行部分膀胱切除术(92.3%),9 例患者行全膀胱切除术(7.7%)。31 例患者接受了新辅助治疗(26.5%)。主要并发症发生率为 20.5%。R0 切除率为 87.2%。47%的患者病理检查证实有膀胱侵犯。34 例患者为 pN+,60 例(51.3%)患者接受了辅助化疗。中位随访时间为 33.8 个月。3 年总生存率和无病生存率分别为 82.9%和 59.5%。局部复发率和远处复发率分别为 14.5%和 18.8%,17 例(14.5%)局部复发患者均为膀胱复发,尽管这些患者中索引手术时并无病理证实的膀胱侵犯。7 例(7/55)有组织学膀胱侵犯的患者发生了膀胱局部复发,而 4 例无原发性膀胱侵犯的患者也发生了膀胱局部复发(P=0.343)。新辅助治疗、膀胱切除术类型和辅助治疗均未影响局部复发(P>0.445 每项)。与 R0 膀胱切除术相比,R1 膀胱切除术的局部复发率更高(63% vs 10%;P<0.0001)。
临床疑似膀胱侵犯即使没有组织学证实的膀胱侵犯也会增加局部复发的风险。只有完全切除且达到 R0 切缘才能降低局部复发率。即使没有病理上的膀胱侵犯,也需要仔细、详细的术后监测。